Related Experiment Video
Updated: Oct 20, 2025

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Circulating miR-122 in patients with non-toxic acute acetaminophen ingestions
Jacob A Lebin1, Anita Mudan1, Yu Zhang2
1Department of Emergency Medicine, University of California, San Francisco, CA, USA.
Abstract:
Introduction: MicroRNA-122 (miR-122) is a novel biomarker of liver injury and has been proposed as an early predictor of acetaminophen-associated hepatotoxicity. However, there is little data on miR-122 in patients with nontoxic acute acetaminophen ingestions.Methods: This was an observational study of patients with a history of acute acetaminophen ingestion and measured acetaminophen concentrations below the treatment nomogram and who did not receive antidotal treatment. Fold increase in miR-122 expression was measured from the remnant sample corresponding with the timed serum acetaminophen concentration used to determine need for antidotal treatment.Results: Ten patients met inclusion criteria with a four-hour acetaminophen concentration below the nomogram line (mean: 73.4 µg/mL). There was no significant difference in mean fold change of miR-122 expression between the acetaminophen exposed patients and negative controls [(0.82, IQR: 0.27, 0.77) vs (1.24, IQR: 0.54, 1.98), p = 0.33].Conclusion: miR-122 was not elevated in patients with acute acetaminophen ingestions with timed acetaminophen concentrations below the nomogram line. These data help to further characterize patterns of miR-122 in patients with acute acetaminophen exposures.
Insights
MicroRNA-122 (miR-122) did not elevate in patients with acute acetaminophen ingestions below toxic levels. This study provides key data on miR-122 patterns in non-toxic acetaminophen exposures.
Area of Science:
- Biochemistry
- Toxicology
- Molecular Biology
Background:
- MicroRNA-122 (miR-122) is a recognized biomarker for liver injury.
- miR-122 has been investigated as a potential early predictor of acetaminophen-induced liver toxicity.
Purpose of the Study:
- To investigate miR-122 levels in patients with acute acetaminophen ingestions below the threshold for hepatotoxicity.
- To determine if miR-122 elevation occurs in non-toxic acetaminophen exposures.
Main Methods:
- Observational study of patients with acute acetaminophen ingestion.
- Measured serum acetaminophen concentrations and miR-122 expression.
- Compared miR-122 levels in patients below the treatment nomogram with healthy controls.
Main Results:
- Ten patients with 4-hour acetaminophen concentrations below the nomogram were included (mean 73.4 µg/mL).
- No significant difference in mean fold change of miR-122 expression was observed between acetaminophen-exposed patients and controls (p=0.33).
Conclusions:
- miR-122 levels were not elevated in patients with acute acetaminophen ingestions below the nomogram line.
- These findings contribute to understanding miR-122 behavior in non-toxic acetaminophen exposures.
More Related Videos
Related Concept Videos
Prevention of Further Absorption of Poison
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...

